HTG Molecular Diagnostics (HTGM) Reports Q4 Loss of $0.76/Share

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q4 EPS of ($0.76), versus ($0.83) reported last year. Revenue for the quarter came in at $1.5 million, versus $1.22 million reported last year.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15